DiNuzzo Private Wealth
PCVX icon

DiNuzzo Private Wealth’s Vaxcyte PCVX Stock Holding History

DiNuzzo Private Wealth’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$740 Buy
13
+10
+333% +$583 ﹤0.01% 975
2026
Q2 		$175 Buy
+3
New +$163 ﹤0.01% 1261
2025
Q1 		– Sell
-1
Closed -$82 – 1411
2024
Q4 		$82 Buy
+1
New +$99 ﹤0.01% 1348

Other funds holding PCVX

Virginia Retirement Systems
Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
BG Investment Services
BG Investment Services Hagatna, Guam $673M AUM 14.41% 1-Year Est. Return
Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Inspire Investing
Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return
Avior Wealth Management
Avior Wealth Management Omaha, Nebraska $3.79B AUM 15.36% 1-Year Est. Return
Values First Advisors
Values First Advisors Gray, Tennessee $213M AUM 20.51% 1-Year Est. Return
SignatureFD
SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return
Teza Capital Management
Teza Capital Management Chicago, Illinois $112M AUM 57.58% 1-Year Est. Return

DiNuzzo Private Wealth's PCVX Position: Q3 2026 in Review

DiNuzzo Private Wealth increased its Vaxcyte (PCVX) stake by 333% in Q3 2026, buying an estimated $583 and bringing the position to 13 shares worth $740. The position accounts for ﹤0.01% of the portfolio, ranked #975.

DiNuzzo Private Wealth first reported a position in PCVX in Q4 2024 and has held it in 3 quarters since. 59 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.

  • DiNuzzo Private Wealth held 13 shares of Vaxcyte worth $740 as of Q3 2026.
  • DiNuzzo Private Wealth bought 10 Vaxcyte shares in Q3 2026, an estimated $583.
  • Vaxcyte made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q3 2026, its #975 holding.
  • DiNuzzo Private Wealth first reported a position in Vaxcyte in Q4 2024 and has held it in 3 quarters since.
  • 59 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q3 2026, filed 16 Oct 2026.